Clinical Trial Update: Pemetrexed and Platinum Use in the Neoadjuvant Setting for Resectable Stage II and IIIA Lung Adenocarcinoma (ECTOP-1002) [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating pemetrexed and platinum as neoadjuvant therapy for resectable stage II-IVA lung adenocarcinoma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lung Adenocarcinoma

Drugs mentioned

• Pemetrexed (pemetrexed)
• Platinum (Platinum-based chemotherapy)

Snippet

Sponsor: Fudan University | Conditions: Lung Adenocarcinoma | Phase 2 | Status: COMPLETED